Please login to the form below

personalised medicines

This page shows the latest personalised medicines news and features for those working in and with pharma, biotech and healthcare.

Immuno-oncology, personalised medicine continues to drive pharma sector

Coming in after I-O and personalised medicines as the top most impactful trends was the growing role of real-world evidence and a rise in the use of electronic health ... Personalised medicines have been identified as key treatments by the UK’s

Latest news

Incyte signs lymphoma deal worth up to $1.1bn with MorphoSys

It may have an advantage over these drugs however, as CAR-T therapies are personalised medicines which have complex manufacturing processes.
Personalised medicine can improve treatment, but access still an issue

Barriers to access could harm uptake of potentially transformative therapies. Personalised medicines such as gene therapies may improve identification of optimal treatment but gaining access to these treatments still poses an ... For example, NHS England
Greater Manchester backs move to outcome-based payment

able to access new and innovative medicines as early as possible and delivering better value for money.”. ... We’re set to see more personalised medicines being launched over the next few years, so additional data will help ensure those treatments
CAR-Ts go head-to-head after NICE clears Kymriah in DLBCL

Meindert Boysen, director of the Centre for Health Technology Evaluation at NICE said: “Recommending another revolutionary CAR T-cell therapy for adults with lymphoma represents a step forward for personalised medicine. ... Providing the latest cutting
Hancock says UK genome service is now ‘rolling out’

The news was welcomed by Mike Thompson, chief executive of the Association of the British Pharma Industry (ABPI), who said: “The health secretary’s focus on earlier diagnosis and more personalised ... medicines for cancer and rare diseases is great

More from news
Approximately 13 fully matching, plus 57 partially matching documents found.

Latest Intelligence

The dawn of a new era in medical education

By Annlouise Pendse. We are living in a pivotal moment in medical history. The first wave of personalised medicines is now available and is changing the way diseases are identified and ... delivering often complex personalised medicine.
The first, my last, my everything

This growing empowerment arguably has its biggest impact in the arena of high-value medicines. ... We need a better understanding of patients. We’re heading rapidly towards personalised medicines, yet we’re still not personalising the value that we
Genomics integration: can the NHS rise to the challenge?

We can then make sure personalised medicine treatment is targeted to the individual so they get the best treatment at the right point in time. ... Last year, NHS England announced that it will focus on earlier diagnosis and more personalised medicines
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”

National Institute for Health Research (NIHR) and the UK’s medicines regulator the MHRA. ... The partnership will aim to enable faster and more efficient drug research, generate more robust evidence to support treatment value, and ultimately provide
Cell and gene therapy

In the case of a personalised therapy like CAR-T, the cost of the raw materials, the components and the labour that goes into manufacturing, testing and logistics are all for ... For traditional biopharmaceutical products one batch equals many doses,

More from intelligence
Approximately 4 fully matching, plus 17 partially matching documents found.

Latest appointments

Eduardo Bravo becomes head of EBE

Coming from the field of advanced therapies, he helps bridge the gap between the lab and personalised medicines within a thriving and innovative ecosystem.”.
Horizon Discovery appoints executive director

1996. Horizon is a UK-based biotech focused on genomics research and the development of personalised medicines.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

In the precision medicine era, the line between products and services is blurred

Precision and personalised medicines are more than products, they are services in their own right. ... Personalised and precision medicines are naturally patient-centred (compared to traditional pharmaceuticals), as the individual patient is central to
Five key trends in precision and personalised healthcare

Personalised and precision medicines represent an evolution in healthcare, in which traditional clinical information and new data points including genetic data, and healthcare technology come together to match the right patient ... Innovative pricing
'Fake news': battling misinformation in healthcare

As the pharmaceutical landscape becomes more complex and as personalised and precision medicines emerge, these stories are increasingly impacting patients and healthcare professionals.
Mastering the precision medicine opportunity

Personalised: Developing and choosing medicines that will change the patient experience, from one of hope to one of certainty of response. ... In personalised medicine, we ask if we can use a particular treatment in a patient.
Medopad: the up and coming unicorn transforming remote patient monitoring

The company has developed a platform for creating modular apps which can be personalised across numerous patient cohorts, using a combination of artificial intelligence, rich data analysis and a strong understanding ... Healthcare is becoming more precise

More from PMHub
Approximately 0 fully matching, plus 9 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company

Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

Surviving cancer: a new era for patients: Now more than ever, a shift in perspective is needed...
Crisis? No problem!: Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?: First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....